Trial NCT00588822

View at ClinicalTrials.gov 
Org. Study IDs: 1191-04
Secondary IDs: UL1RR024150

Last trial update was posted on 2014-05-06

MeSH Interventions

Rituximab

MeSH Conditions

Monoclonal Gammopathy of Undetermined Significance Paraproteinemias Peripheral Nervous System Diseases Precancerous Conditions

Other Conditions

Precancerous Condition

Stopping Reasons

Discontinuation due to the high response rate at the 1st stage and slow accrual.

Limitations And Caveats

The study was discontinued at the first stage to the high response rate and slow accrual.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID